Breast cancer
Surgery first vs chemotherapy first in early triple negative and HER2 positive breast cancer.
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine and surgery or a procedure
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial CentreMumbaiDirections ↗
Registry summary (technical)
PRe-operative ChemoTherapy versus Surgery first with peri-operative interventions in Early triple negative and HER2 enriched breast- an open label, phase 3, randomized controlled trial (PRaCTiSE) - PRaCTiSE
Sponsor: Tata Memorial Centre
CTRI/2024/02/063118 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 5 Oct 2026 · read by us 5 Nov 2026